Cargando…

Glucocorticoid excess and COVID-19 disease

The pandemic of coronavirus disease (COVID-19), a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is causing high and rapid morbidity and mortality. Immune system response plays a crucial role in controlling and resolving the viral infection. Exogenous or endogenous g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guarnotta, Valentina, Ferrigno, Rosario, Martino, Marianna, Barbot, Mattia, Isidori, Andrea M., Scaroni, Carla, Ferrante, Angelo, Arnaldi, Giorgio, Pivonello, Rosario, Giordano, Carla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538187/ https://www.ncbi.nlm.nih.gov/pubmed/33025384 http://dx.doi.org/10.1007/s11154-020-09598-x

Ejemplares similares

COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess
por: Pivonello, Rosario, et al.
Publicado: (2020)

Incretin Response to Mixed Meal Challenge in Active Cushing’s Disease and after Pasireotide Therapy
por: Barbot, Mattia, et al.
Publicado: (2022)

The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence”
por: Pivonello, Rosario, et al.
Publicado: (2019)

The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas
por: Regazzo, Daniela, et al.
Publicado: (2022)

Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool
por: Minnetti, Marianna, et al.
Publicado: (2022)

Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
por: Isidori, Andrea M, et al.
Publicado: (2020)

A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score
por: Parasiliti-Caprino, Mirko, et al.
Publicado: (2021)

Consideration on TMPRSS2 and the risk of COVID-19 infection in Cushing’s syndrome
por: Barbot, Mattia, et al.
Publicado: (2020)

COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency
por: Isidori, A. M., et al.
Publicado: (2020)

Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant
por: Pivonello, Rosario, et al.
Publicado: (2022)

Diabetes Mellitus Secondary to Cushing’s Disease
por: Barbot, Mattia, et al.
Publicado: (2018)

The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome
por: Barbot, Mattia, et al.
Publicado: (2019)

Second-Line Tests in the Diagnosis of Adrenocorticotropic Hormone-Dependent Hypercortisolism
por: Pinelli, Silvia, et al.
Publicado: (2021)

Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients
por: Ceccato, Filippo, et al.
Publicado: (2021)

Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia
por: Barbot, Mattia, et al.
Publicado: (2022)

SUN-358 Dual Release Hydrocortisone as a New Treatment for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Simeoli, Chiara, et al.
Publicado: (2019)

Prediction of diabetes mellitus induced by steroid overtreatment in adrenal insufficiency
por: Guarnotta, Valentina, et al.
Publicado: (2022)

Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials
por: Pivonello, Rosario, et al.
Publicado: (2020)

Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
por: Cignarella, Andrea, et al.
Publicado: (2020)

Low-dose short synacthen test with salivary cortisol in patients with suspected central adrenal insufficiency
por: Ceccato, Filippo, et al.
Publicado: (2021)

Vitamin D Deficiency in Cushing’s Disease: Before and After Its Supplementation
por: Guarnotta, Valentina, et al.
Publicado: (2022)

Long-term outcomes of conventional and novel steroid replacement therapy on bone health in primary adrenal insufficiency
por: Guarnotta, Valentina, et al.
Publicado: (2022)

Smoke, alcohol and drug addiction and male fertility
por: Sansone, Andrea, et al.
Publicado: (2018)

Hepatic Steatosis Index in Acromegaly: Correlation with Insulin Resistance Regardless of the Disease Control
por: Ciresi, Alessandro, et al.
Publicado: (2018)

Very Low-Calorie Ketogenic Diet: A Potential Application in the Treatment of Hypercortisolism Comorbidities
por: Guarnotta, Valentina, et al.
Publicado: (2022)

Approach to patients with pseudo-Cushing’s states
por: Scaroni, Carla, et al.
Publicado: (2019)

Smoke, alcohol and drug addiction and female fertility
por: de Angelis, Cristina, et al.
Publicado: (2020)

Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre
por: Mondin, Alessandro, et al.
Publicado: (2023)

Myoinositol supplementation in the treatment of gestational diabetes mellitus: effects on glycaemic control and maternal-foetal outcomes
por: Guarnotta, Valentina, et al.
Publicado: (2022)

Nutritional Intervention in Cushing’s Disease: The Ketogenic Diet’s Effects on Metabolic Comorbidities and Adrenal Steroids
por: Guarnotta, Valentina, et al.
Publicado: (2023)

Practical Considerations for the Management of Cushing's Disease and COVID-19: A Case Report
por: Beretta, Federica, et al.
Publicado: (2020)

Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency
por: Guarnotta, V, et al.
Publicado: (2019)

Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease
por: Guarnotta, Valentina, et al.
Publicado: (2020)

Correction to: One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus
por: Radellini, Stefano, et al.
Publicado: (2021)

Metabolic Profile in a Cohort of Young Sicilian Patients with Klinefelter's Syndrome: The Role of Irisin
por: Radellini, Stefano, et al.
Publicado: (2022)

One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus
por: Radellini, Stefano, et al.
Publicado: (2021)

Impact of Chemical Endocrine Disruptors and Hormone Modulators on the Endocrine System
por: Guarnotta, Valentina, et al.
Publicado: (2022)

Irisin: A Possible Marker of Adipose Tissue Dysfunction in Obesity
por: Tomasello, Laura, et al.
Publicado: (2023)

Pasireotide-Induced Shrinkage in GH and ACTH Secreting Pituitary Adenoma: A Systematic Review and Meta-Analysis
por: Mondin, Alessandro, et al.
Publicado: (2022)

Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit
por: Provvisiero, Donatella Paola, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3lgjr2lopa1frmhtvkgfp6qu0e